CARDIFF ONCOLOGY, INC. (CRDF) Total liabilities 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) total liabilities at each fiscal year-end, per SEC filings.
$16.5MFY2025 · since FY2016: $24.2M → $16.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16.5M | +15.8% |
| FY2024 | $14.2M | +19.7% |
| FY2023 | $11.9M | +20.8% |
| FY2022 | $9.8M | +7.9% |
| FY2021 | $9.1M | +38.9% |
| FY2020 | $6.6M | +13.7% |
| FY2019 | $5.8M | +41.3% |
| FY2018 | $4.1M | -29.3% |
| FY2017 | $5.8M | -76.1% |
| FY2016 | $24.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice